Large-scale testing (Phase 3)Study completedNCT04571944
What this trial is testing
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
Who this might be right for
Delirium
Merck Sharp & Dohme LLC 207